Aescin improves behavioural outcomes after spinal cord injury (SCI).
Aescin alleviates immune cell infiltration, decreases MMP3 and MMP9 enzyme levels and reduces NO production after SCI.
Aescin restricts oxidative stress and damage to macromolecules after SCI.
Aescin reduces neuronal loss, demyelination, tissue destruction, oedema and apoptosis after SCI.
Aescin increases expression of HO-1 and suppresses activation of the NF-κB pathway after SCI.